New York, New York (PRWEB) March 20, 2013
Zamansky & Associates LLC notifies all investors in Intuitive Surgical Inc. (“Intuitive Surgical”), the Sunnyvale-California manufacturer of the da Vinci surgical systems, that it is investigating the Company for possible violations of federal securities laws. The investigation concerns Intuitive Surgical’s representations related to its robotic-assisted minimally invasive surgery systems during the period of April 18, 2012 through March 14, 2013.
On March 15, 2013, Russ Britt of Marketwatch reported that Intuitive Surgical’s stock price hit a 52-week low, after falling 11% on February 28, 2013. On February 28, the Washington Post reported that the United States Food and Drug Administration was probing Intuitive Surgical over the safety of its products, and increases in reported “adverse incidents.” Intuitive Surgical’s revenues from robotic-related products generated most of its $2.2 billion in revenue in 2012, the Post reported.
The investigation concerns whether Intuitive Surgical’s knowledge of these issues, and disclosures to investors. According to Jake Zamansky, any regulatory or health problems plaguing the Company’s driver of revenues would be of material concern to any investor or shareholder.
What Intuitive Surgical Investors Can Do
If you are a shareholder of Intuitive Surgical and would like to discuss your legal rights, you may, without obligation or cost to you, email jake(at)zamansky(dot)com or call the law firm at (212) 742-1414.
About Zamansky & Associates
Zamansky & Associates LLC is one of the leading law firms specializing in securities fraud and financial services arbitration and class action litigation. We represent both individual and institutional investors. Our practice is nationally recognized for our ability to aggressively prosecute cases and recover losses.
To learn more about Zamansky, please visit our website, http://www.zamansky.com.
Zamansky & Associates, LLC
50 Broadway - 32nd Floor
New York, NY 10004
Jake Zamansky, 212-742-1414